These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11766119)

  • 21. Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis.
    Bruce S; Epinette WW; Funicella T; Ison A; Jones EL; Loss R; McPhee ME; Whitmore C
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):755-9. PubMed ID: 7929921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes.
    Koo J; Blum RR; Lebwohl M
    J Am Acad Dermatol; 2006 Oct; 55(4):637-41. PubMed ID: 17010744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Kalb RE; Bagel J; Korman NJ; Lebwohl MG; Young M; Horn EJ; Van Voorhees AS;
    J Am Acad Dermatol; 2009 Jan; 60(1):120-4. PubMed ID: 19103363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of vitamin D analog use for the treatment of psoriasis.
    Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
    J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
    Downs AM
    Acta Derm Venereol; 2006; 86(1):57-8. PubMed ID: 16585991
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
    Singh S; Reddy DC; Pandey SS
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):61-5. PubMed ID: 10863225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical vitamin D analogs.
    Kieffer MA
    Dermatol Nurs; 2004 Feb; 16(1):89-90, 93, 100. PubMed ID: 15022510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.
    Lebwohl M; Yoles A; Lombardi K; Lou W
    J Am Acad Dermatol; 1998 Sep; 39(3):447-50. PubMed ID: 9738781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcipotriene for psoriasis.
    Med Lett Drugs Ther; 1994 Aug; 36(928):70-1. PubMed ID: 8035754
    [No Abstract]   [Full Text] [Related]  

  • 33. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.
    Pariser DM; Pariser RJ; Breneman D; Lebwohl M; Kalb R; Moore J; Moss H; Parker C; Fiedler V
    Arch Dermatol; 1996 Dec; 132(12):1527. PubMed ID: 8961897
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial.
    Patel T; Bhutani T; Busse KL; Koo J
    Cutis; 2011 Sep; 88(3):149-54. PubMed ID: 22017069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in topical sequential therapy for psoriasis.
    Koo JY
    Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compatibility of calcipotriene with other topical medications.
    Patel B; Siskin S; Krazmien R; Lebwohl M
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):1010-1. PubMed ID: 9632021
    [No Abstract]   [Full Text] [Related]  

  • 37. Generalized pustular psoriasis precipitated by topical calcipotriol ointment.
    Tamiya H; Fukai K; Moriwaki K; Ishii M
    Int J Dermatol; 2005 Sep; 44(9):791-2. PubMed ID: 16135156
    [No Abstract]   [Full Text] [Related]  

  • 38. Photosensitivity associated with combined UV-B and calcipotriene therapy.
    McKenna KE; Stern RS
    Arch Dermatol; 1995 Nov; 131(11):1305-7. PubMed ID: 7503575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An observation study evaluating the efficacy of tazarotene plus corticosteroid in treating plaque psoriasis in patients switched from treatment with calcipotriene +/- corticosteroid.
    Tanghetti EA;
    Cutis; 2000 Dec; 66(6 Suppl):12-8. PubMed ID: 11147086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.